Pancreatic Cancer Market Trends

  • Report ID: 5299
  • Published Date: Oct 09, 2024
  • Report Format: PDF, PPT

Pancreatic Cancer Market Trends

Growth Drivers

  • Rising Geriatric Population Across the World with Reduced Immunity – The chances of developing cancer cells in the body can increase with the age of the person. As per the estimations in 2023, more than 1 in 6 people in America which is 80 million people are now the age 65 and above.
  • Growing Number of Research Projects- The increasing number of financially funded research projects by the National Cancer Institute to develop medications and treatments is projected to propel the market’s growth.
  • Increasing Incidence of Cancers related to the Digestive System and Stomach owing to Unhealthy Foods –Consumption of red meat, processed meat, and meals are high in saturated fats, alcohol, and fructose-containing foods and drinks may raise the chance of developing pancreatic cancer.

Challenges

  • Side Effects of Radiation and Chemotherapy – The side effects of chemotherapy include pain, dizziness, fever, vomiting, and frequent bowel movement and the side effects of radiation therapy include diarrhea, shortness of breath, change in taste, and urinary and bladder problems. All these factors are estimated to be the reason for the hampering of market growth.
  • Rising Cost of Drug Development and Treatment
  • Stringent Government Regulatory Guidelines

Pancreatic Cancer Market: Key Insights

Base Year

2024

Forecast Year

2025-2037

CAGR

13.3%

Base Year Market Size (2024)

USD 2.48 billion

Forecast Year Market Size (2037)

USD 12.57 billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 5299
  • Published Date: Oct 09, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of pancreatic cancer is evaluated at USD 2.74 billion.

The pancreatic cancer market size was valued at USD 2.48 billion in 2024 and is projected to exceed USD 12.57 billion by the end of 2037, expanding at over 13.3% CAGR during the forecast period i.e., between 2025-2037. The market growth is propelled by the increasing geriatric population around the world and the rising prevalence of obesity.

North America industry is predicted to hold largest revenue share 32% by 2037, owing to increasing adoption of new technologies for the treatment of cancer cases in the region.

The major players in the market are Amgen Inc., Novartis AG Pfizer Inc., Aduro Biotech Inc., Clovis Oncology Inc., NewLink Genetics Corp, Infinity Pharmaceuticals, Inc., and Celgene Corporation.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample